Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria

Details for Australian Patent Application No. 2006282722 (hide)

Owner Cerenis Therapeutics Holdings S.A.

Inventors Dasseux, Jean-Louis

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006282722

PCT Pub. Number WO2007/023476

Priority 60/712,295 26.08.05 US

Filing date 25 August 2006

Wipo publication date 1 March 2007

International Classifications

C07K 14/775 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/023476 Priority application(s): WO2007/023476

9 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006282735-Cellular communication system for reducing the effects of radiation emitted from cellular phone antennas

2006282701-Hydroxyl polymer fiber fibrous structures and processes for making same